Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals.
read more
Paragon Bioservices announced the appointment of John R. Mosack as the Vice President of Manufacturing in Baltimore and Adam Sachs as the Vice President of Program Management and Strategic Client Alliance.
read more
Harbour BioMed and Chia Tai Tianqing announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics.
read more
ReForm Biologics has expanded its patent portfolio with the issuance of U.S. Patent No. 10,279,048 (the ‘048 patent).
read more
Catalent announced financial results for the third quarter of fiscal year 2019, which ended March 31, 2019.
read more
WuXi AppTec announced it has acquired Pharmapace, a US-based clinical research services company with expertise of providing high quality biometrics services.
read more
LSNE has received GMP certification from Brazil's National Health Surveillance Agency - ANVISA following an inspection and audit of its manufacturing facility in Manchester, NH in February.
read more
Haemonetics and CSL Plasma have announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma.
read more
The FDA has posted warning letters to five companies who produce products labeled as homeopathic for significant violations of CGMP regulations.
read more
Cumberland Pharmaceuticals has entered into an exclusive agreement with China's Winhealth Pharma Group for the licensing rights of Acetadote®.
read more
Elligo Health Research has announced the launch of its innovative IntElligo Research Stack™ clinical technology.
read more
Dr. Reddy’s Laboratories announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin® for Injection.
read more
CURE Pharmaceutical has closed on the previously announced acquisition of Chemistry Holdings, a formulation technology company that is develops delivery systems for a variety of industries.
read more
IDLogiq® innovations have been selected by the FDA for the Pilot Project Program under the DSCSA to prototype and develop a system that can address the national security of the drug supply chain.
read more
PharmScript announced the acquisition of Rx Med, a long-term care pharmacy located near Nashville, Tennessee.
read more